Fidia Past Earnings Performance
Past criteria checks 0/6
Fidia has been growing earnings at an average annual rate of 4.4%, while the Machinery industry saw earnings growing at 25.3% annually. Revenues have been declining at an average rate of 14.7% per year.
Key information
4.4%
Earnings growth rate
19.2%
EPS growth rate
| Machinery Industry Growth | 19.4% |
| Revenue growth rate | -14.7% |
| Return on equity | -142.6% |
| Net Margin | -22.1% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Investors Give Fidia S.p.A. (BIT:FDA) Shares A 34% Hiding
Oct 18
It's Down 40% But Fidia S.p.A. (BIT:FDA) Could Be Riskier Than It Looks
Aug 29Further Upside For Fidia S.p.A. (BIT:FDA) Shares Could Introduce Price Risks After 28% Bounce
Jun 20Estimating The Fair Value Of Fidia S.p.A. (BIT:FDA)
May 28Risks Still Elevated At These Prices As Fidia S.p.A. (BIT:FDA) Shares Dive 31%
Feb 13Is Fidia (BIT:FDA) A Risky Investment?
Dec 23Fidia S.p.A.'s (BIT:FDA) Business Is Trailing The Industry But Its Shares Aren't
Oct 04Revenue & Expenses Breakdown
How Fidia makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 29 | -6 | 11 | 0 |
| 31 Mar 24 | 29 | -4 | 11 | 0 |
| 31 Dec 23 | 29 | -1 | 12 | 0 |
| 30 Sep 23 | 26 | -3 | 12 | 0 |
| 30 Jun 23 | 24 | -5 | 12 | 0 |
| 31 Mar 23 | 24 | 1 | 11 | 0 |
| 31 Dec 22 | 25 | 6 | 11 | 0 |
| 31 Dec 21 | 24 | -3 | 11 | 0 |
| 31 Dec 20 | 22 | -6 | 11 | 0 |
| 30 Jun 20 | 38 | -4 | 15 | 0 |
| 31 Mar 20 | 43 | -4 | 17 | 0 |
| 31 Dec 19 | 46 | -4 | 17 | 0 |
| 30 Sep 19 | 57 | -2 | 19 | 0 |
| 30 Jun 19 | 55 | -3 | 19 | 0 |
| 31 Mar 19 | 61 | -1 | 19 | 0 |
| 31 Dec 18 | 59 | -1 | 19 | 0 |
| 30 Sep 18 | 49 | -4 | 19 | 0 |
| 30 Jun 18 | 54 | -3 | 19 | 0 |
| 31 Mar 18 | 47 | -4 | 19 | 0 |
| 31 Dec 17 | 47 | -3 | 19 | 0 |
| 30 Sep 17 | 51 | -1 | 20 | 0 |
| 30 Jun 17 | 50 | -1 | 19 | 0 |
| 31 Mar 17 | 59 | 1 | 19 | 0 |
| 31 Dec 16 | 59 | 2 | 19 | 0 |
| 30 Sep 16 | 58 | 2 | 19 | 0 |
| 30 Jun 16 | 59 | 3 | 19 | 0 |
| 31 Mar 16 | 63 | 4 | 19 | 0 |
| 31 Dec 15 | 61 | 3 | 19 | 0 |
| 30 Sep 15 | 63 | 5 | 18 | 0 |
| 30 Jun 15 | 65 | 5 | 18 | 0 |
| 31 Mar 15 | 55 | 2 | 18 | 0 |
| 31 Dec 14 | 55 | 3 | 17 | 0 |
| 30 Sep 14 | 49 | 0 | 17 | 0 |
| 30 Jun 14 | 44 | -1 | 17 | 0 |
| 31 Mar 14 | 48 | 0 | 17 | 0 |
| 31 Dec 13 | 45 | -1 | 17 | 0 |
Quality Earnings: FDA is currently unprofitable.
Growing Profit Margin: FDA is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: FDA is unprofitable, but has reduced losses over the past 5 years at a rate of 4.4% per year.
Accelerating Growth: Unable to compare FDA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: FDA is unprofitable, making it difficult to compare its past year earnings growth to the Machinery industry (-1.2%).
Return on Equity
High ROE: FDA has a negative Return on Equity (-142.63%), as it is currently unprofitable.